2,2-diphenyl-1-picrylhydrazyl (DPPH) is certainly one of the most widely used free radical in several applications, because of its high stability. Unfortunately, there are few works dealing with its stability in...
The electrochemical behaviour of 2,2‐diphenyl‐1‐picrylhydrazyl (DPPH) incorporated in a carbon paste electrode (CPE/DPPH1 %) was studied. Two electrochemical systems assigned to the free‐radical were perfectly defined, including System I where DPPH acts as reducing agent and System II where it acts as an oxidant. Although System II was reversible and remains stable after several consecutive potential scans, System I shows high peak current ratio (Ipa/Ipc=1.4) and a significant decrease in signal intensity when performing consecutive potentials scans. This phenomenon was due to the chemical reaction of the oxidized DPPH and the hydroxide ions present at the vicinity of the electrode surface. This new compound formed was responsible of a new system (System III). Systems II and III were highly pH‐dependent, in agreement with the proton exchange involved in these electrochemical transformations. When experiments were performed in the presence of ascorbic acid (AAH2), only System I was found to be ideal for monitoring the antioxidant activity of AAH2. System I clearly shows a linear dependency between the peak currents of DPPH as a function of AAH2 concentration. This linear response was used to determine the IC50 of ascorbic acid (0.56 μM) in the described experimental condition. This effect was confirmed when controlled amount of tea extracts were used instead of AAH2, confirming the efficiency of CPE/DPPH1 % for the electrochemical evaluation of antioxidant properties.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.